Fig 1.
Participant disposition.
Table 1.
Distribution of participants who received VARIZIG.
Table 2.
Baseline demographics (safety population).
Fig 2.
Incidence of varicella by high-risk participant group.
CI confidence interval.
Fig 3.
Incidence of varicella by timing of administration.
P values were determined using a 2-sided Fisher’s exact test. CI confidence interval.
Fig 4.
Incidence of varicella by absence or presence of concomitant antiviral therapy.
CI confidence interval.
Table 3.
Safety summary.